CFI and age-related macular degeneration: This study raises the prospect that patients with early features of AMD (including those with high‐risk features such as RPD) could undergo a blood test to measure serum FI levels, and those expressing low serum FI levels and pathogenic rare CFI gene variants could potentially benefit from an early FI supplementation approach.